The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,048
Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P., & workgroup, T. A. (2004) · Critical Care · doi:10.1186/cc2872 · Cited by 6,781
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Scandalios, J. G. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000700003 · Cited by 1,142
Hidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A., & Wong-Beringer, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2138 · Cited by 860
Levine, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/491709 · Cited by 838
Arbeit, R. D., Maki, D., Tally, F. P., Campanaro, E., Eisenstein, B. I., & Daptomycin 98-01 and 99-01 Investigators (2004) · Clinical Infectious Diseases · doi:10.1086/420818 · Cited by 689
Lodise, T. P., Lomaestro, B., Graves, J., & Drusano, G. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01602-07 · Cited by 574
Lodise, T. P., Patel, N., Lomaestro, B. M., Rodvold, K. A., & Drusano, G. L. (2009) · Clinical Infectious Diseases · doi:10.1086/600884 · Cited by 554
Rubinstein, E., Cammarata, S. K., Oliphant, T. H., Wunderink, R. G., & the Linezolid Nosocomial Pneumonia Study Group (2001) · Clinical Infectious Diseases · doi:10.1086/318486 · Cited by 440
Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981
Farber, B. F., & Moellering, R. C. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.1.138 · Cited by 432
Fibroblasts Can Be Genetically Modified to Produce Excitable Cells Capable of Electrical Coupling
Kizana, E., Ginn, S. L., Allen, D. G., Ross, D. L., & Alexander, I. E. (2005) · Circulation · doi:10.1161/01.cir.0000153812.64956.ef · Cited by 382
Vancomycin: A 50-Year Reassessment
Moellering, R. C. (2006) · Clinical Infectious Diseases · doi:10.1086/491708 · Cited by 275
Bosso, J. A., Nappi, J., Rudisill, C., Wellein, M., Bookstaver, P. B., Swindler, J., & Mauldin, P. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00168-11 · Cited by 252
Wilcox, M. H., Tack, K. J., Bouza, E., Herr, D. L., Ruf, B. R., Ijzerman, M. M., Croos‐Dabrera, R. V., Kunkel, M. J., & Knirsch, C. (2009) · Clinical Infectious Diseases · doi:10.1086/595686 · Cited by 223
Transporters and Renal Drug Elimination
Lee, W., & Kim, R. B. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121856 · Cited by 222
FAGON, J.-Y., PATRICK, H., HAAS, D. W., TORRES, A., GIBERT, C., CHEADLE, W. G., FALCONE, R. E., ANHOLM, J. D., PAGANIN, F., FABIAN, T. C., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.3.9904115 · Cited by 214
Cataldo, M. A., Tacconelli, E., Grilli, E., Pea, F., & Petrosillo, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr442 · Cited by 204
Incidence and Risk Factors Influencing the Development of Vancomycin Nephrotoxicity in Children
McKamy, S., Hernandez, E., Jahng, M., Moriwaki, T., Deveikis, A., & Le, J. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.08.019 · Cited by 186
Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy
Wong-Beringer, A., Joo, J., Tse, E., & Beringer, P. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.10.013 · Cited by 178
A prospective study of adverse reactions associated with vancomycin therapy
Sorrell, T. C., & Collignon, P. J. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.2.235 · Cited by 175
Ingram, P. R., Lye, D. C., Tambyah, P. A., Goh, W. P., Tam, V. H., & Fisher, D. A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn080 · Cited by 163
Cano, E. L., Haque, N. Z., Welch, V. L., Cely, C. M., Peyrani, P., Scerpella, E. G., Ford, K. D., Zervos, M. J., Ramirez, J. A., & Kett, D. H. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.12.013 · Cited by 161
Increasing Vancomycin Serum Trough Concentrations and Incidence of Nephrotoxicity
Pritchard, L., Baker, C., Leggett, J., Sehdev, P., Brown, A., & Bayley, K. B. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.07.025 · Cited by 161
Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury
Waring, W. S., & Moonie, A. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.615319 · Cited by 160
Vancomycin-Associated Nephrotoxicity: Grave Concern or Death by Character Assassination?
Hazlewood, K. A., Brouse, S. D., Pitcher, W. D., & Hall, R. G. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.05.031 · Cited by 154
Vancomycin Ototoxicity and Nephrotoxicity
Bailie, G. R., & Neal, D. (1988) · Medical Toxicology · doi:10.1007/bf03259891 · Cited by 150
Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination
Goetz, M. B., & Sayers, J. F. B. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/32.2.325 · Cited by 145
Cimino, M. A., Rotstein, C., Slaughter, R. L., & Emrich, L. J. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90947-8 · Cited by 128
Zimmermann, A. E., Katona, B. G., & Plaisance, K. I. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04335.x · Cited by 123
Dieterich, C., Puey, A., Lyn, S., Swezey, R. R., Furimsky, A. M., Fairchild, D., Mirsalis, J. C., & Ng, H. H. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn203 · Cited by 115
Renal Transport of Antibiotics and Nephrotoxicity: a Review
Fanos, V., & Cataldi, L. (2001) · Journal of Chemotherapy · doi:10.1179/joc.2001.13.5.461 · Cited by 110
Vancomycin toxicity: a prospective study
Mellor, J., Kingdom, J. C., CAFFERKEY, M. T., & Keane, C. T. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/15.6.773 · Cited by 110
Elting, L. S., Rubenstein, E. B., Kurtin, D., Rolston, K. V. I., Fangtang, J. T., Martin, C. G., RAAD, I. I., Whimbey, E. E., Manzullo, E. F., & Bodey, G. P. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2597::aid-cncr27>3.0.co;2-l · Cited by 109
Recent changes in vancomycin use in renal failure
Vandecasteele, S. J., & Vriese, A. S. D. (2010) · Kidney International · doi:10.1038/ki.2010.35 · Cited by 106
Hermsen, E. D., Hanson, M., Sankaranarayanan, J., Stoner, J. A., Florescu, M. C., & Rupp, M. E. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903413514 · Cited by 102
Mild Nephrotoxicity Associated With Vancomycin Use
Downs, N. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390080053013 · Cited by 102
King, D. W., & Smith, M. A. (2004) · Toxicology in Vitro · doi:10.1016/j.tiv.2004.03.013 · Cited by 97
Minejima, E., Choi, J. J., Beringer, P. M., Lou, M., Tse, E., & Wong‐Beringer, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00173-11 · Cited by 94
Heme Oxygenase -1 Gene Therapy: Recent Advances and Therapeutic Applications
Abraham, N. G., Asija, A., Drummond, G., & Peterson, S. J. (2007) · Current Gene Therapy · doi:10.2174/156652307780363134 · Cited by 93
Protective Effects of Different Antioxidants and Amrinone on Vancomycin‐Induced Nephrotoxicity
Çelik, İ., Cihangiroğlu, M., İlhan, N., Akpolat, N., & Akbulut, H. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto_153.x · Cited by 92
Çetin, H., Olgar, Ş., Öktem, F., et al. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04695.x · Cited by 81
Influence of Vancomycin on Renal Function in Critically Ill Patients after Cardiac Surgery
Hutschala, D., Kinstner, C. M., Skhirdladze, K., et al. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181a97272 · Cited by 78
Toxicology of Vancomycin in Laboratory Animals
Wold, J. S., & Turnipseed, S. A. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.supplement_2.s224 · Cited by 77
Risk of Nephrotoxicity with Combination Vancomycin‐Aminoglycoside Antibiotic Therapy
Pauly, D. J., Musa, D. M., Lestico, M. R., Lindstrom, M. J., & Hetsko, C. M. (1990) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1990.tb03566.x · Cited by 65
Tanaka, A., Aiba, T., Otsuka, T., Suemaru, K., Nishimiya, T., Inoue, T., Murase, M., Kurosaki, Y., & Araki, H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00661-09 · Cited by 65
Nishino, Y., Takemura, S., Minamiyama, Y., Hirohashi, K., Tanaka, H., Inoue, M., Okada, S., & Kinoshita, H. (2002) · Redox Report · doi:10.1179/135100002125000884 · Cited by 59
Cohen, E., Dadashev, A., Drucker, M., Samra, Z., Rubinstein, E., & Garty, M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.155 · Cited by 58
A higher dose of vancomycin in continuous infusion is needed in critically ill patients
Jeurissen, A., Sluyts, I., & Rutsaert, R. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.09.004 · Cited by 57
Renal tolerance and pharmacokinetics of vancomycin in rats
Marre, R., Schulz, E., Anders, T., & Sack, K. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/14.3.253 · Cited by 56
Lack of Vancomycin-associated Nephrotoxicity in Newborn Infants: A Case–Control Study
Bhatt‐Mehta, V., Schumacher, R. E., Faix, R. G., et al. (1999) · PEDIATRICS · doi:10.1542/peds.103.4.e48 · Cited by 51
Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits
Toyoguchi, T., Takahashi, S., Hosoya, J., Nakagawa, Y., & Watanabe, H. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.1985 · Cited by 50
Nahata, M. C. (2009) · Chemotherapy · doi:10.1159/000238512 · Cited by 49
Medication Reconciliation and Hypertension Control
Persell, S. D., Bailey, S. C., Tang, J. Z., Davis, T. C., & Wolf, M. S. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.06.027 · Cited by 47
Fauconneau, B., Favrelière, S., Pariat, C., Génévrier, A., Courtois, P., Piriou, A., & Bouquet, S. (1997) · Renal Failure · doi:10.3109/08860229709026256 · Cited by 38
Kralovicová, K., Spanik, S., Halko, J., Netriová, J., Mrazova-Studena, M., Novotný, J., Grausova, S., Koren, P., Krupova, I., Demitrovicova, A., et al. (1997) · Journal of Chemotherapy · doi:10.1179/joc.1997.9.6.420 · Cited by 38
Glycopeptides and nephrotoxicity
Chow, A. W., & Azar, R. (1994) · Intensive Care Medicine · doi:10.1007/bf01713979 · Cited by 38
Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans
Prabaker, K. K., Tran, T. P. ‐., Pratummas, T., Goetz, M. B., & Graber, C. J. (2011) · Journal of Hospital Medicine · doi:10.1002/jhm.946 · Cited by 37
Protective Effect of Inactive Ingredients against Nephrotoxicity of Vancomycin Hydrochloride in Rats
Hodoshima, N., Nakano, Y., Izumi, M., Mitomi, N., Nakamura, Y., Aoki, M., Gyobu, A., Shibasaki, S., & Kurosawa, T. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.68 · Cited by 31
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Mp, G., Dk, B., & Jl, S. (1989) · PubMed · Cited by 31
Biomarkers are transforming our understanding of AKI
Chawla, L. S., & Kellum, J. A. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.216 · Cited by 29
Chrononephrotoxicity in Rat of a Vancomycin and Gentamicin Combination
Fauconneau, B., de Lemos, E., Pariat, C., Bouquet, S., Courtois, P., & Piriou, A. (1992) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1992.tb00516.x · Cited by 27
Influence of fosfomycin and tobramycin on vancomycin-induced nephrotoxicity
Marre, R., Schulz, E., Hedtke, D., & Sack, K. (1985) · Infection · doi:10.1007/bf01642811 · Cited by 22
Malacarne, P., Bergamasco, S., & Donadio, C. (2006) · Chemotherapy · doi:10.1159/000093269 · Cited by 19
Hodoshima, N., Masuda, S., & Inui, K. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.419 · Cited by 18
Niveau de preuve pour le suivi thérapeutique pharmacologique de la vancomycine
Jelassi, M. L., Benlmouden, A., Lefeuvre, S., Mainardi, J., & Billaud, E. M. (2011) · Therapies · doi:10.2515/therapie/2011005 · Cited by 10
[Glycopeptides and the newborn infant's kidney].
(1998) · Cited by 3
Cited by
Melatonin ameliorates the drug induced nephrotoxicity: Molecular insights
Raza, Z., & Naureen, Z. (2020) · Nefrología · doi:10.1016/j.nefro.2019.06.009 · Cited by 43
Metadata
- Authors
- Elyasi, S., Khalili, H., Dashti-Khavidaki, S., & Mohammadpour, A.
- Venue
- European Journal of Clinical Pharmacology
- Published
- 2012-03-13
- Volume
- 68
- Issue
- 9
- Pages
- 1243-1255
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2042841791
- Cited by
- 436
- References
- 69
- FWCI
- 18.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.